drugset / Trial / NCT04943159
Afamelanotide in Patients Suffering With Acne Vulgaris
RandomizedParallel-groupOpen-labelTreatment
Summary
This study aims to evaluate the effect of afamelanotide on the facial inflammatory acne-related lesions in patients with mild to moderate acne vulgaris, including tolerability of afamelanotide by patients with moderate acne vulgaris and effects of the treatment on quality of life in eligible patients.
Timeline
- Start
- 2010-08-24
- Primary completion
- 2011-03-08
- Completion
- 2011-03-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Afamelanotide | Peptide | — | Subcutaneous |